Digital health for allergen immunotherapy.

Area of Science:

• Digital Health
• Medical Technology
• Immunotherapy

Background:

• The COVID-19 pandemic accelerated the adoption of digital healthcare technologies.
• Mobile applications and communication platforms are increasingly used for healthcare services, particularly for chronic disease management.
• Allergen immunotherapy (AIT) requires consistent treatment and follow-up, making it suitable for digital health interventions.

Purpose of the Study:

• To summarize current knowledge on the application and potential of digital health technologies in allergen immunotherapy.
• To explore how digital tools can support various aspects of AIT, from patient stratification to ongoing communication.
• To highlight the role of digital health in creating flexible, blended care models for AIT patients.

Main Methods:

• Review of recent advancements in digital healthcare technologies relevant to AIT.
• Analysis of the integration of mobile applications and communication platforms in chronic disease management.
• Synthesis of literature on patient stratification, decision support, and patient-doctor communication in digital AIT settings.

Main Results:

• Digital health technologies are rapidly evolving and being implemented, especially post-pandemic.
• These technologies offer significant benefits for managing chronic conditions like AIT, which require long-term care.
• Potential applications include personalized decision support, improved patient stratification, and enhanced patient-doctor communication within blended care frameworks.

Conclusions:

• Digital health technologies present a valuable opportunity to optimize allergen immunotherapy delivery and patient management.
• The integration of these technologies can lead to more flexible, personalized, and effective care pathways for AIT.
• Further exploration and implementation of digital tools are recommended to fully leverage their potential in AIT.